ONVO

Organovo Stock Price

0.68
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
0.68
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00 0.0% 0.68 0.00 0.00 0.00 0.68 20:00:00
Bid Price Ask Price Spread Spread % News
0.684 0.693 0.009 1.3% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.68 USD

Organovo Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 88.82M 130.62M 101.45M $ 2.20M $ - -0.15 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Organovo News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONVO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.71980.780.67050.7219237907,680-0.0398-5.53%
1 Month0.60850.870.58060.7324681,411,3780.071511.75%
3 Months0.560.870.45970.67695831,500,0920.1221.43%
6 Months0.32650.930.19330.5795071,206,1460.3535108.27%
1 Year0.250.930.19330.5149125919,2080.43172.0%
3 Years2.102.37990.19330.96269211,013,072-1.42-67.62%
5 Years2.814.710.19331.801,008,368-2.13-75.8%

Organovo Description

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.